Quantitative Assessment of Skeletal Tumor Burden in Bone Scintigraphy as a prognostic biomarker in Radium-223-dichloride Therapy

被引：0
|
作者：
Soeiro, P. [1 ]
Silva, R. [1 ,2 ]
Gil, P. [1 ]
Pena, H. [3 ]
Cantinho, G. [3 ]
Costa, G. [1 ,4 ]
Lima, A. [1 ]
Ferreira, I. [1 ]
Alburqueque, A. [1 ]
Gouveia, P. [5 ]
Pedroso Lima, J. [1 ,2 ,4 ]
机构：
[1] Univ Hosp Ctr Coimbra, Coimbra, Portugal
[2] ICNAS Inst Nucl Sci Appl Hlth, Coimbra, Portugal
[3] Univ Lisbon, Fac Med, Inst Nucl Med, Lisbon, Portugal
[4] Univ Coimbra, Fac Med, Coimbra, Portugal
[5] Hosp Ctr Porto, Porto, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0669
引用
收藏
页码：S566 / S567
页数：2
相关论文
共 50 条
  • [1] Quantification of skeletal tumor burden on bone scintigraphy for prediction of overall survival in Radium-223 therapy
    Fosbol, M. O.
    Petersen, P. M.
    Kjaer, A.
    Mortensen, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S132 - S132
  • [2] Automatic bone scan index for therapy response assessment of radium-223-dichloride (Ra-223) therapy in advanced prostate cancer
    Sakretz, M.
    Kurth, J.
    Schwarzenboeck, S. M.
    Krause, B. J.
    Heuschkel, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S699 - S699
  • [3] Quantitative SPECT/CT of bone scans for prediction of response to Radium-223-Dichloride treatment in patients with mCRPC
    Dittmann, Helmut
    Kaltenbach, Sabine
    Kupferschlaeger, Juergen
    la Fougare, Christian
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [4] Bone scan index as metastatic bone disease quantifier and predictor of radium-223-dichloride biochemical response
    Roque, Valentin
    Jessop, Maryam
    Pereira, Luisa
    Gape, Paul
    Dizdarevic, Sabina
    Sousa, Eva
    Carolino, Elizabete
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (06) : 588 - 596
  • [5] Evaluating the efficacy of radium-223 dichloride using conventional bone scintigraphy
    Full, Richard
    Neumann, Donald
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [6] Bone-specific therapy with radium-223 dichloride
    Tauber, R.
    Gschwend, J.
    Scheidhauer, K.
    Eiber, M.
    Kroenke, M.
    UROLOGE, 2017, 56 (01): : 24 - 31
  • [7] Radium-223-Dichloride in Castration-Resistant Metastatic Prostate Cancer: Therapy Assessment with 11C-choline PET/CT and Bone Scan
    Ghedini, P.
    Graziani, T.
    Rizzini, E. Lodi
    Lima, G.
    Bossert, I.
    Ceci, F.
    Montini, G.
    Pettinato, C.
    Monari, F.
    Dionisi, V.
    Morganti, A.
    Castellucci, P.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S131 - S132
  • [8] Evaluation of Alpha-Therapy with Radium-223-Dichloride in Castration Resistant Metastatic Prostate Cancer-the Role of Gamma Scintigraphy in Dosimetry and Pharmacokinetics
    Kairemo, Kalevi
    Joensuu, Timo
    Rasulova, Nigora
    Kiljunen, Timo
    Kangasmaki, Aki
    DIAGNOSTICS, 2015, 5 (03): : 358 - 368
  • [9] Investigation into the feasability of using EPDs to perform simple dosimetry modelling on Radium-223-dichloride therapy patients
    Shaylor, A. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S426 - S427
  • [10] Response Evaluation to Radium-223-Dichloride in Castration-Resistant Metastatic Prostate Cancer using 11C-choline PET/CT and Bone Scintigraphy
    Ghedini, P.
    Graziani, T.
    Rizzini, E. Lodi
    Lima, G. M.
    Matti, A.
    Bossert, I.
    Ceci, F.
    Montini, G. C.
    Monari, F.
    Morganti, A.
    Castellucci, P.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S102 - S103
12345